177 related articles for article (PubMed ID: 15093869)
1. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Pellizzon GG; Grines CL; Cox DA; Stuckey T; Tcheng JE; Garcia E; Guagliumi G; Turco M; Lansky AJ; Griffin JJ; Cohen DJ; Aymong E; Mehran R; O'Neill WW; Stone GW
J Am Coll Cardiol; 2004 Apr; 43(8):1368-74. PubMed ID: 15093869
[TBL] [Abstract][Full Text] [Related]
2. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
[TBL] [Abstract][Full Text] [Related]
3. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
[TBL] [Abstract][Full Text] [Related]
4. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials.
Brodie BR; Gersh BJ; Stuckey T; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Grines CL; Cox D; Parise H; Prasad A; Lansky AJ; Mehran R; Stone GW
J Am Coll Cardiol; 2010 Jul; 56(5):407-13. PubMed ID: 20650362
[TBL] [Abstract][Full Text] [Related]
5. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
[TBL] [Abstract][Full Text] [Related]
6. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.
Sadeghi HM; Stone GW; Grines CL; Mehran R; Dixon SR; Lansky AJ; Fahy M; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD
Circulation; 2003 Dec; 108(22):2769-75. PubMed ID: 14638545
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
Nikolsky E; Mehran R; Sadeghi HM; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2009 Jul; 2(7):624-32. PubMed ID: 19628185
[TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
9. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
10. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
Méndez-Eirín E; Flores-Ríos X; García-López F; Pérez-Pérez AJ; Estévez-Loureiro R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos RA; Vázquez Rodríguez JM; Vázquez-González N; Castro-Beiras A
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):227-33. PubMed ID: 22281285
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up.
Wita K; Berger-Kucza A; Filipecki A; Turski M; Bochenek T; Wróbel W; Lelek M; Weglarz P; Elzbieciak M; Trusz-Gluza M
Coron Artery Dis; 2010 Sep; 21(6):325-9. PubMed ID: 20453641
[TBL] [Abstract][Full Text] [Related]
13. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
Halkin A; Singh M; Nikolsky E; Grines CL; Tcheng JE; Garcia E; Cox DA; Turco M; Stuckey TD; Na Y; Lansky AJ; Gersh BJ; O'Neill WW; Mehran R; Stone GW
J Am Coll Cardiol; 2005 May; 45(9):1397-405. PubMed ID: 15862409
[TBL] [Abstract][Full Text] [Related]
14. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial).
Nikolsky E; Grines CL; Cox DA; Garcia E; Tcheng JE; Sadeghi M; Mehran R; Lansky AJ; Na Y; Stone GW
Am J Cardiol; 2007 Apr; 99(8):1055-61. PubMed ID: 17437727
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trial.
Bakhai A; Stone GW; Grines CL; Murphy SA; Githiora L; Berezin RH; Cox DA; Stuckey T; Griffin JJ; Tcheng JE; Cohen DJ;
Circulation; 2003 Dec; 108(23):2857-63. PubMed ID: 14610016
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Lansky AJ; Pietras C; Costa RA; Tsuchiya Y; Brodie BR; Cox DA; Aymong ED; Stuckey TD; Garcia E; Tcheng JE; Mehran R; Negoita M; Fahy M; Cristea E; Turco M; Leon MB; Grines CL; Stone GW
Circulation; 2005 Apr; 111(13):1611-8. PubMed ID: 15811868
[TBL] [Abstract][Full Text] [Related]
18. Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention.
Perkan A; Vitrella G; Barbati G; De Monte A; D'Agata B; Merlo M; Giannini F; Della Grazia E; Rakar S; Salvi A; Igidbashian D; Morgera T; Zalukar W; Sinagra G
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):127-35. PubMed ID: 22343257
[TBL] [Abstract][Full Text] [Related]
19. Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction.
Nikolsky E; Sadeghi HM; Effron MB; Mehran R; Lansky AJ; Na Y; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Stuckey TD; Turco M; Carroll JD; Grines CL; Stone GW
Am J Cardiol; 2005 Aug; 96(4):474-81. PubMed ID: 16098296
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
